Copyright Reports & Markets. All rights reserved.

Global Follicle Stimulating Hormone Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Follicle Stimulating Hormone Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Follicle Stimulating Hormone Market Size Growth Rate by Product
      • 1.4.2 Recombinant FSH
      • 1.4.3 Urinary FSH
    • 1.5 Market by End User
      • 1.5.1 Global Follicle Stimulating Hormone Market Size Growth Rate by End User
      • 1.5.2 Infertility Treatment
      • 1.5.3 Assisted Reproductive Technology
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Follicle Stimulating Hormone Market Size
      • 2.1.1 Global Follicle Stimulating Hormone Revenue 2014-2025
      • 2.1.2 Global Follicle Stimulating Hormone Sales 2014-2025
    • 2.2 Follicle Stimulating Hormone Growth Rate by Regions
      • 2.2.1 Global Follicle Stimulating Hormone Sales by Regions
      • 2.2.2 Global Follicle Stimulating Hormone Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Follicle Stimulating Hormone Sales by Manufacturers
      • 3.1.1 Follicle Stimulating Hormone Sales by Manufacturers
      • 3.1.2 Follicle Stimulating Hormone Sales Market Share by Manufacturers
      • 3.1.3 Global Follicle Stimulating Hormone Market Concentration Ratio (CR5 and HHI)
    • 3.2 Follicle Stimulating Hormone Revenue by Manufacturers
      • 3.2.1 Follicle Stimulating Hormone Revenue by Manufacturers (2014-2019)
      • 3.2.2 Follicle Stimulating Hormone Revenue Share by Manufacturers (2014-2019)
    • 3.3 Follicle Stimulating Hormone Price by Manufacturers
    • 3.4 Follicle Stimulating Hormone Manufacturing Base Distribution, Product Types
      • 3.4.1 Follicle Stimulating Hormone Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Follicle Stimulating Hormone Product Type
      • 3.4.3 Date of International Manufacturers Enter into Follicle Stimulating Hormone Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Follicle Stimulating Hormone Sales by Product
    • 4.2 Global Follicle Stimulating Hormone Revenue by Product
    • 4.3 Follicle Stimulating Hormone Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Follicle Stimulating Hormone Breakdown Data by End User

    6 North America

    • 6.1 North America Follicle Stimulating Hormone by Countries
      • 6.1.1 North America Follicle Stimulating Hormone Sales by Countries
      • 6.1.2 North America Follicle Stimulating Hormone Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Follicle Stimulating Hormone by Product
    • 6.3 North America Follicle Stimulating Hormone by End User

    7 Europe

    • 7.1 Europe Follicle Stimulating Hormone by Countries
      • 7.1.1 Europe Follicle Stimulating Hormone Sales by Countries
      • 7.1.2 Europe Follicle Stimulating Hormone Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Follicle Stimulating Hormone by Product
    • 7.3 Europe Follicle Stimulating Hormone by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Follicle Stimulating Hormone by Countries
      • 8.1.1 Asia Pacific Follicle Stimulating Hormone Sales by Countries
      • 8.1.2 Asia Pacific Follicle Stimulating Hormone Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Follicle Stimulating Hormone by Product
    • 8.3 Asia Pacific Follicle Stimulating Hormone by End User

    9 Central & South America

    • 9.1 Central & South America Follicle Stimulating Hormone by Countries
      • 9.1.1 Central & South America Follicle Stimulating Hormone Sales by Countries
      • 9.1.2 Central & South America Follicle Stimulating Hormone Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Follicle Stimulating Hormone by Product
    • 9.3 Central & South America Follicle Stimulating Hormone by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Follicle Stimulating Hormone by Countries
      • 10.1.1 Middle East and Africa Follicle Stimulating Hormone Sales by Countries
      • 10.1.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Follicle Stimulating Hormone by Product
    • 10.3 Middle East and Africa Follicle Stimulating Hormone by End User

    11 Company Profiles

    • 11.1 Merck Serono
      • 11.1.1 Merck Serono Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Merck Serono Follicle Stimulating Hormone Products Offered
      • 11.1.5 Merck Serono Recent Development
    • 11.2 MSD
      • 11.2.1 MSD Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 MSD Follicle Stimulating Hormone Products Offered
      • 11.2.5 MSD Recent Development
    • 11.3 IBSA
      • 11.3.1 IBSA Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 IBSA Follicle Stimulating Hormone Products Offered
      • 11.3.5 IBSA Recent Development
    • 11.4 Ferring
      • 11.4.1 Ferring Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Ferring Follicle Stimulating Hormone Products Offered
      • 11.4.5 Ferring Recent Development
    • 11.5 Livzon
      • 11.5.1 Livzon Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Livzon Follicle Stimulating Hormone Products Offered
      • 11.5.5 Livzon Recent Development
    • 11.6 Techwell
      • 11.6.1 Techwell Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Techwell Follicle Stimulating Hormone Products Offered
      • 11.6.5 Techwell Recent Development
    • 11.7 GenSci
      • 11.7.1 GenSci Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 GenSci Follicle Stimulating Hormone Products Offered
      • 11.7.5 GenSci Recent Development
    • 11.8 Gedeon Richter
      • 11.8.1 Gedeon Richter Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Gedeon Richter Follicle Stimulating Hormone Products Offered
      • 11.8.5 Gedeon Richter Recent Development
    • 11.9 Teva
      • 11.9.1 Teva Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Teva Follicle Stimulating Hormone Products Offered
      • 11.9.5 Teva Recent Development

    12 Future Forecast

    • 12.1 Follicle Stimulating Hormone Market Forecast by Regions
      • 12.1.1 Global Follicle Stimulating Hormone Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Follicle Stimulating Hormone Revenue Forecast by Regions 2019-2025
    • 12.2 Follicle Stimulating Hormone Market Forecast by Product
      • 12.2.1 Global Follicle Stimulating Hormone Sales Forecast by Product 2019-2025
      • 12.2.2 Global Follicle Stimulating Hormone Revenue Forecast by Product 2019-2025
    • 12.3 Follicle Stimulating Hormone Market Forecast by End User
    • 12.4 North America Follicle Stimulating Hormone Forecast
    • 12.5 Europe Follicle Stimulating Hormone Forecast
    • 12.6 Asia Pacific Follicle Stimulating Hormone Forecast
    • 12.7 Central & South America Follicle Stimulating Hormone Forecast
    • 12.8 Middle East and Africa Follicle Stimulating Hormone Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Follicle Stimulating Hormone Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
      Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). It is mainly used to treat infertility disease and assisted reproductive technology. At present, this product cannot be replaced in the treatment of infertility.
      Currently, There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are top two companies in the world. In 2016, Merck Serono takes about 58.70% of global follicle stimulating hormone revenue. MSD takes about 26.29% of global follicle stimulating hormone revenue.
      The global Follicle Stimulating Hormone market is valued at 1250 million US$ in 2018 and will reach 1730 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Follicle Stimulating Hormone market based on company, product type, end user and key regions.

      This report studies the global market size of Follicle Stimulating Hormone in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Follicle Stimulating Hormone in these regions.
      This research report categorizes the global Follicle Stimulating Hormone market by top players/brands, region, type and end user. This report also studies the global Follicle Stimulating Hormone market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Merck Serono
      MSD
      IBSA
      Ferring
      Livzon
      Techwell
      GenSci
      Gedeon Richter
      Teva

      Market size by Product
      Recombinant FSH
      Urinary FSH
      Market size by End User
      Infertility Treatment
      Assisted Reproductive Technology

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Follicle Stimulating Hormone market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Follicle Stimulating Hormone market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Follicle Stimulating Hormone companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Follicle Stimulating Hormone submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Follicle Stimulating Hormone are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Follicle Stimulating Hormone market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now